• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Crocus Sativus vs Methylphenidate for ADHD

Crocus Sativus vs Methylphenidate for ADHD

November 21, 2019
Jess Levy, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Jess Levy, MD Dr. Levy has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review of: Baziar S et al, J Child Adolesc Psychopharmacol 2019;29(3):205–212

The search for an equally effective, yet better tolerated alternative to stimulant medications continues. We often hear reports on the benefits of various non-pharmaceutical supplements. Now we have a new study looking at saffron (Crocus sativus). Saffron is reported to affect dopamine, norepinephrine, NMDA, and GABA-α receptors, and it can improve depression, anxiety, and memory.

In this 6-week, randomized, double-blinded study conducted in an outpatient clinic affiliated with Tehran University, 54 youth (20% female, average age 8–9 years old) with ADHD were randomized to receive either saffron or methylphenidate (MPH). Psychiatric and developmental comorbidities other than ODD were excluded. MPH was titrated using a fixed schedule up to 1 mg/kg per day in divided doses. Saffron was dosed at 20 mg/day for kids weighing under 30 kg, and 30 mg/day for kids weighing more. Outcome data included ADHD-RS parent and teacher rating scales at baseline and weeks 3 and 6, as well as side effects. The ADHD-RS may be unfamiliar to people in the US but has been found to be reliable and valid across multiple cultures.

Juveniles receiving saffron did just as well as those who received MPH in both the parent and teacher rating scales. Both groups showed symptom reduction at week 3 and week 6, with no statistically significant differences in outcomes between treatment groups at either point in time. Parents reported an average ADHD-RS score improvement of 23.72 points for saffron (baseline score: 34.20 ± 4.69, week 3 score: 15.68 ± 5.86, week 6 score: 10.48 ± 3.80) versus a 23.04 point reduction in the MPH group (baseline: 33.56 ± 6.48; week 3: 13.56 ± 5.78: week 6: 10.52 ± 5.18). Teachers reported an average total score reduction of 9.56 points for saffron vs 9.24 for MPH.

Interestingly, there were no statistically significant differences in side effects, including insomnia and decreased appetite, though there was a trend toward improvement with the saffron group (16% reported anorexia or insomnia with saffron versus 46% in the MPH group).

CCPR’S TAKE
The results of this study are so impressive that they seem too good to be true. Hopefully, larger studies that include a placebo group will verify whether saffron indeed works just as well as methylphenidate with equal or better tolerability. Also, the dose of methylphenidate was low, and the market cost of saffron is exorbitant, not to mention the potential issues with pill-to-pill variability given the lack of regulatory oversight. Even so, for families who are not ready to embark on the road of prescription medications, saffron may be worth considering.
Child Psychiatry
KEYWORDS adhd attention-deficit-hyperactivity-disorder crocus-sativus methylphenidate saffron
Jess Levy, MD

Heart Rate Changes Linked to ­Emotional Dysregulation

More from this author
www.thecarlatreport.com
Issue Date: November 21, 2019
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Autism in Children and Adolescents, CCPR, November/December 2019
Note From the Editor-in-Chief
Exploring the Potential Neurotoxicity of Antipsychotics in Younger Populations
Managing Irritability in Autism
Engage Those Infants: Maternal Interaction and Autism
Heart Rate Changes Linked to ­Emotional Dysregulation
Weight Gain From Aripiprazole Same as Risperidone
Crocus Sativus vs Methylphenidate for ADHD
DOWNLOAD NOW
Featured Book
  • CMFB2e_Cover.png

    Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

    All the important facts covering child and adolescent psychopharmacology.
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • teen_depression.jpeg
    Child Psychiatry

    Assessment of Non-Suicidal Self-Injury in Children and Adolescents

    Learn how to assess and intervene with NSSI, including ideas for supporting autonomy while addressing the behavior.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.